APP and Alzheimer disease: Here, we compared the effects and structures of the natural products that can modulate either of the two APP processing pathways (secretase- or structure-dependent) on the formation of the Aβ aggregates in AD and summarized the states of the corresponding clinical trials (Table 1 and Table 2).